Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Kidney Disease, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06591104
What this trial is testing

Metabolic Phenotypes of Obesity and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

Who this might be right for
Diabetic Kidney DiseaseObesityMetabolic Syndrome+1 more
Assiut University 71
Post-approval studies (Phase 4)UnknownNCT04242758
What this trial is testing

Phthalates Exposure in Type 2 Diabetic Patients and Diuretic Therapy

Who this might be right for
Renal Function DisorderGlucose Metabolism Disorders
University of Pisa 30
Testing effectiveness (Phase 2)Study completedNCT01756716
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 49
Not applicableStudy completedNCT05071287
What this trial is testing

Metabolism of Low Carbohydrate and Ketogenic Diet

Who this might be right for
Diabetic Kidney DiseaseCognitive FunctionWeight Loss+2 more
The University of Texas Health Science Center at San Antonio 60
Not applicableNot Yet RecruitingNCT07266220
What this trial is testing

Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.

Who this might be right for
Diabetes Mellitus, Type 2Chronic Kidney DiseaseAtherosclerosis
Abdallah Ali Mohammed 96
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Not applicableNot Yet RecruitingNCT07717697
What this trial is testing

Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney Disease
First Affiliated Hospital of Chongqing Medical University 425
Testing effectiveness (Phase 2)Study completedNCT05593575
What this trial is testing

Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Shanghai Pharmaceuticals Holding Co., Ltd 305
Not applicableActive Not RecruitingNCT07338435
What this trial is testing

"Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney DiseasePeritoneal Dialysis (PD)+2 more
Instituto Mexicano del Seguro Social 100
Large-scale testing (Phase 3)UnknownNCT03262363
What this trial is testing

Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2Polymorphism
Unidad de Investigacion Medica en Enfermedades Renales 176
Not applicableStudy completedNCT06778018
What this trial is testing

Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Nephropathies
Riphah International University 60
Testing effectiveness (Phase 2)Ended earlyNCT01752985
What this trial is testing

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bristol-Myers Squibb 319
Not applicableUnknownNCT03445247
What this trial is testing

Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy Type 2
Chang Gung Memorial Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01447147
What this trial is testing

Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyType 2 Diabetes Mellitus
Amgen 332
Early research (Phase 1)Study completedNCT05374343
What this trial is testing

The Pharmacokinetics, Pharmacodynamics, and Safety of Rongliflozin in Type 2 Diabetic Subjects With Renal Impairment

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 32
Large-scale testing (Phase 3)Study completedNCT04881123
What this trial is testing

SER150 vs Placebo in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Serodus AS 20
Testing effectiveness (Phase 2)Study completedNCT00160225
What this trial is testing

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Who this might be right for
Hypertension
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Testing effectiveness (Phase 2)UnknownNCT04626323
What this trial is testing

Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2Kidney Disease, ChronicKidney Injury
Hospital Alemão Oswaldo Cruz 60
Testing effectiveness (Phase 2)Study completedNCT00464776
What this trial is testing

Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 26
Next Page